FR3043556B1 - Utilisation de composes oligosaccharidiques pour activer l'angiogenese - Google Patents

Utilisation de composes oligosaccharidiques pour activer l'angiogenese Download PDF

Info

Publication number
FR3043556B1
FR3043556B1 FR1561056A FR1561056A FR3043556B1 FR 3043556 B1 FR3043556 B1 FR 3043556B1 FR 1561056 A FR1561056 A FR 1561056A FR 1561056 A FR1561056 A FR 1561056A FR 3043556 B1 FR3043556 B1 FR 3043556B1
Authority
FR
France
Prior art keywords
oligosaccharide compounds
activate angiogenesis
angiogenesis
activate
oligosaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1561056A
Other languages
English (en)
Other versions
FR3043556A1 (fr
Inventor
Marielle Bouschbacher
Christelle Laurensou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Urgo Recherche Innovation et Developpement
Original Assignee
Laboratoires Urgo SAS
Urgo Recherche Innovation et Developpement
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Urgo SAS, Urgo Recherche Innovation et Developpement filed Critical Laboratoires Urgo SAS
Priority to FR1561056A priority Critical patent/FR3043556B1/fr
Priority to EP16812984.9A priority patent/EP3377072A1/fr
Priority to PCT/FR2016/052964 priority patent/WO2017085397A1/fr
Priority to US15/776,643 priority patent/US20180325930A1/en
Publication of FR3043556A1 publication Critical patent/FR3043556A1/fr
Application granted granted Critical
Publication of FR3043556B1 publication Critical patent/FR3043556B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Abstract

La présente invention a pour objet un oligosaccharide polysulfaté synthétique ayant 1 à 4 unités oses, ses sels, ou ses complexes, à une concentration supérieure ou égale à 70 mg/mL, pour son utilisation pour activer l'angiogénèse, en particulier pour activer l'angiogénèse lors de la cicatrisation des plaies.
FR1561056A 2015-11-17 2015-11-17 Utilisation de composes oligosaccharidiques pour activer l'angiogenese Active FR3043556B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR1561056A FR3043556B1 (fr) 2015-11-17 2015-11-17 Utilisation de composes oligosaccharidiques pour activer l'angiogenese
EP16812984.9A EP3377072A1 (fr) 2015-11-17 2016-11-15 Utilisation de composes oligosaccharidiques pour activer l'angiogenese
PCT/FR2016/052964 WO2017085397A1 (fr) 2015-11-17 2016-11-15 Utilisation de composes oligosaccharidiques pour activer l'angiogenese
US15/776,643 US20180325930A1 (en) 2015-11-17 2016-11-15 Use of Oligosaccharide Compounds for Activating Angiogenesis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1561056A FR3043556B1 (fr) 2015-11-17 2015-11-17 Utilisation de composes oligosaccharidiques pour activer l'angiogenese
FR1561056 2015-11-17

Publications (2)

Publication Number Publication Date
FR3043556A1 FR3043556A1 (fr) 2017-05-19
FR3043556B1 true FR3043556B1 (fr) 2020-01-10

Family

ID=55025232

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1561056A Active FR3043556B1 (fr) 2015-11-17 2015-11-17 Utilisation de composes oligosaccharidiques pour activer l'angiogenese

Country Status (4)

Country Link
US (1) US20180325930A1 (fr)
EP (1) EP3377072A1 (fr)
FR (1) FR3043556B1 (fr)
WO (1) WO2017085397A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3113583A1 (fr) 2020-08-26 2022-03-04 Urgo Recherche Innovation Et Developpement Utilisation de composes oligosaccharidiques pour augmenter l’oxygenation de la peau lors du traitement des plaies ischemiques

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1576522A (en) 1977-05-24 1980-10-08 Colorplast International A S Sealing material for ostomy devices
DK147035C (da) 1980-12-05 1984-09-03 Coloplast As Hudplade
AU607690B2 (en) * 1985-12-24 1991-03-14 Marion Laboratories, Inc. Use of synthetic sulfated saccharides to enhance wound healing
DK505488D0 (da) * 1987-12-21 1988-09-09 Bar Shalom Daniel Middel og anvendelse af samme
FR2783412B1 (fr) 1998-09-18 2000-12-15 Lhd Lab Hygiene Dietetique Compresse non adherente sterile
ITMI20012188A1 (it) * 2001-10-19 2003-04-19 Interalta S R L Sali d'argento del saccarosio - ottosolfato
DE102004034786A1 (de) 2004-07-19 2006-03-16 Patent-Treuhand-Gesellschaft für elektrische Glühlampen mbH Glühlampe mit carbidhaltigem Leuchtkörper
FR2977798B1 (fr) * 2011-07-13 2016-07-29 Urgo Lab Utilisation de composes oligosaccharidiques pour la prevention et le traitement des cicatrices pathologiques
US20170182125A1 (en) * 2014-05-23 2017-06-29 Reponex Pharmaceuticals Aps Compositions for promoting the healing of wounds

Also Published As

Publication number Publication date
EP3377072A1 (fr) 2018-09-26
US20180325930A1 (en) 2018-11-15
WO2017085397A1 (fr) 2017-05-26
FR3043556A1 (fr) 2017-05-19

Similar Documents

Publication Publication Date Title
CY1120941T1 (el) Παραγωγα φαινυλοτριαζολιου υποκατεστημενα με υδροξυαλκυλιο και χρησεις αυτων
CL2018001488A1 (es) Formulación farmacéutica acuosa del anticuerpo anti-pd-l1 avelumab
PH12017502107A1 (en) Triazole agonists of the apj receptor
MA34146B1 (fr) Formulations oralles et sels lipophiles de methylnaltrexone
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
FR3012725B1 (fr) Compositions d'agents de lutte biologique, leur procede de preparation et leurs utilisations
EA201790726A1 (ru) Фармацевтическая композиция для лечения язвенного колита
AR093527A1 (es) 6-((S)-1-1-[5-(2-HIDROXI-ETOXI)-PIRIDIN-2-IL]1H-PIRAZOL-3-IL-ETIL)-3H-1,3-BENZOTIAZOL-2-ONA COMO UN ANTAGONISTA DEL RECEPTOR AMPA DEPENDIENTE DE TARP-g 8
ECSP18009366A (es) Antagonistas del receptor de cgrp
EA201890212A1 (ru) Новое применение сульфата декстрана
TR201900665T4 (tr) Diyabetik nefropatinin tedavi yöntemi.
FR3043556B1 (fr) Utilisation de composes oligosaccharidiques pour activer l'angiogenese
TR201907567T4 (tr) Esnek hortumların paketlenmesi için makine.
FR2992862A1 (fr) Utilisation d'un extrait de myrte en tant qu'agent anti-biofilm vis-a-vis de p. acnes
MX2016007224A (es) Vacuna contra el circovirus porcino tipo 2.
MA39108A1 (fr) Nouveau composé pour le traitement de l'hypoglycémie sévère
FR2970649B1 (fr) Procede de traitement cosmetique comprenant la formation in-situ d'une composition aerogel.
PH12016502547A1 (en) Methods for treating infections
MA38623A1 (fr) Système d'adjuvant comprenant un phosphonate polyalcoxylé, un polycarboxylate polyalcoxylé et un retardateur de prise et son utilisation
MA38681A1 (fr) Composés macrocycliques et leurs utilisations comme piégeur d'anions
EA201790117A1 (ru) Фармацевтическая композиция, содержащая 13 глицеридов, и ее препараты и их применение
TR201722910A2 (tr) Deferasi̇roks i̇çeren suda dağilabi̇len tablet formülasyonlari
MX2020004049A (es) Compuestos bencimidazol como productos quimicos agricolas.
位申請者 et al. ekZZB kkkkS kkkkSZ

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20170519

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

TP Transmission of property

Owner name: URGO RECHERCHE INNOVATION ET DEVELOPPEMENT, FR

Effective date: 20191203

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9